Indivior Pharmaceuticals Deal Termination with Reckitt Benckiser Healthcare Limited
Indivior UK Limited and Reckitt Benckiser Healthcare (UK) Limited entered into a Deed of Variation and Termination to accelerate the end of their Copacker Supply Agreement for SUBOXONE and SUBUTEX tablets to January 15, 2027. Indivior has identified a new supplier and will pay RB fixed or capped costs related to the early termination, including asset disposal and redundancy costs. The company stated the financial impact of the termination and the new supplier agreement is not expected to be material.
- Counterparty
- Reckitt Benckiser Healthcare (UK) Limited
- Term
- through Jan 15, 2027